A detailed history of Allspring Global Investments Holdings, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 119,775 shares of ALKS stock, worth $3.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
119,775
Previous 209,535 42.84%
Holding current value
$3.32 Million
Previous $5.05 Million 33.61%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$23.01 - $28.55 $2.07 Million - $2.56 Million
-89,760 Reduced 42.84%
119,775 $3.35 Million
Q2 2024

Jul 26, 2024

BUY
$23.21 - $27.24 $2.06 Million - $2.42 Million
88,834 Added 73.6%
209,535 $5.05 Million
Q1 2024

Apr 18, 2024

SELL
$26.4 - $32.56 $6.78 Million - $8.36 Million
-256,788 Reduced 68.03%
120,701 $3.27 Million
Q4 2023

Jan 25, 2024

BUY
$23.37 - $28.68 $3.96 Million - $4.86 Million
169,385 Added 81.39%
377,489 $10.5 Million
Q3 2023

Oct 27, 2023

BUY
$27.17 - $31.97 $5.65 Million - $6.65 Million
208,104 New
208,104 $5.83 Million
Q2 2023

Jul 18, 2023

SELL
$28.34 - $33.63 $970,871 - $1.15 Million
-34,258 Reduced 78.34%
9,470 $296,000
Q1 2023

Apr 13, 2023

BUY
$25.31 - $29.02 $602,580 - $690,908
23,808 Added 119.52%
43,728 $1.23 Million
Q4 2022

Jan 23, 2023

SELL
$21.94 - $26.24 $4,936 - $5,904
-225 Reduced 1.12%
19,920 $0
Q3 2022

Oct 26, 2022

SELL
$22.0 - $31.87 $1.39 Million - $2.01 Million
-63,217 Reduced 75.83%
20,145 $449,000
Q2 2022

Jul 25, 2022

SELL
$26.4 - $30.54 $2.84 Million - $3.28 Million
-107,418 Reduced 56.3%
83,362 $2.48 Million
Q1 2022

May 02, 2022

SELL
$23.07 - $27.99 $80,352 - $97,489
-3,483 Reduced 1.79%
190,780 $5.02 Million
Q4 2021

Jan 28, 2022

BUY
$21.47 - $32.08 $4.17 Million - $6.23 Million
194,263 New
194,263 $4.52 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.55B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.